ACHN Renal Cell Carcinoma Cells (ACHN)

ACHN cells are a human renal epithelial adenocarcinoma cell line that was established from a tissue sample taken from a patient with renal cell carcinoma. The ACHN cell line was first described in the scientific literature in the early 1970s and has since been widely used in cancer research and preclinical studies.

ACHN cells are characterized by their ability to grow rapidly in cell culture and form tumors when injected into immunocompromised mice. These cells have been utilized in various research areas, including cancer biology, drug discovery, and pharmacology. ACHN cells have been particularly valuable for studying renal cell carcinoma, the type of cancer from which they were originally derived.

Researchers have used ACHN cells to investigate the mechanisms of tumor growth, metastasis, drug resistance, and novel therapeutic targets in renal cell carcinoma. These cells have been instrumental in testing the efficacy and toxicity of potential cancer therapies, including chemotherapy drugs, targeted therapies, and immunotherapies.